Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Merrimack Pharmaceuticals Inc (MACK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	06-2015	03-2015	12-2014	09-2014	06-2014
Assets
Current Assets
Cash & Cash Equivalents	33,765	28,934	35,789	100,424	77,852
Marketable Securities	33,991	62,938	88,340	53,356	14,995
Receivables	1,762	4,248	3,313	2,568	6,605
TOTAL	$74,884	$99,298	$132,065	$162,143	$103,848

Non-Current Assets
PPE Net	18,273	15,749	14,502	14,313	13,731
Intangibles	11,170	11,250	11,330	11,410	11,490
Other Non-Current Assets	716	723	609	736	744
TOTAL	$30,159	$27,722	$26,441	$26,459	$25,965

Total Assets	$105,043	$127,020	$158,506	$188,602	$129,813

Liabilities
Current Liabilities
Short Term Debt	1,058	0	13,315	15,227	11,052
Accounts payable and accrued liabilities	46,626	42,979	37,236	35,989	32,208
Other current liabilities	1,582	1,224	1,285	1,282	1,310
TOTAL	$108,612	$103,709	$111,111	$121,235	$90,853

Non-Current Liabilities
Long Term Debt	123,117	122,080	106,687	103,428	105,135
Deferred Revenues	59,346	59,506	59,275	68,737	46,283
Other Non-Current Liabilities	7,248	6,425	6,451	6,897	7,355
TOTAL	$139,768	$152,529	$149,535	$167,081	$116,072

Total Liabilities	$248,380	$256,238	$260,646	$288,316	$206,925

Shareholders' Equity
Shares Outstanding, K	11,142	11,002	10,693	10,588	10,459
Common Shares	1,108	1,094	1,067	1,057	1,045
Retained earnings	-712,193	-689,460	-655,170	-645,840	-617,939
Other shareholders' equity	-6	-27	-74	-43	-3
TOTAL	$-143,337	$-129,218	$-102,140	$-99,714	$-77,112

Total Liabilities And Equity	$105,043	$127,020	$158,506	$188,602	$129,813